WuXi AppTec IPO tops $353m

By Melissa Fassbender contact

- Last updated on GMT

(Image: WuXi AppTec Co., Ltd.)
(Image: WuXi AppTec Co., Ltd.)
The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

WuXi AppTec's​ initial public offering (IPO) of 104,198,600 shares of common stock was offered on the Shanghai Stock Exchange​ at RMB21.60 per share.

This, equivalent to US$3.39 per share, means the IPO has brought in more than $353m.

According to the company, the funds will be used to build and expand its R&D facilities in China, “further strengthening its capabilities and capacities to better serve global customers and partners.”

The Shanghai-headquartered CDMO operates 26 sites globally and branch offices in China, the US, Germany, UK, Japan, Korea, and Israel. 

Dr. Ge Li, chairman and CEO of WuXi AppTec, said in a statement: "I'm deeply grateful for the great confidence and support we have received from the investment community… It allows us to further focus on our mission and accelerate growth of our enabling platform.”

WuXi AppTec has not responded to a request for comment as of publication.

Related news

Show more

Related products

show more

Innovations in OSD

Innovations in OSD

Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Related suppliers

Follow us

Products

View more

Webinars